Latest news
Tasrif Pharmaceutical granted second US patent for CD155-targeting antibody developed with Abzena's humanisation and immunogenicity platforms - Manufacturing ChemistManufacturing Chemist · Tue, 04 Aug 2026 12:14:55 GMTScientists in Umeå may have cracked the spread of advanced prostate cancer, and the treatment they built could rewrite what comes next - OkDiarioOkDiario · Mon, 03 Aug 2026 18:45:00 GMTBreaking the Wet-Lab Bottleneck in AI-Driven Antibody Discovery - Inside Precision MedicineInside Precision Medicine · Sat, 01 Aug 2026 10:30:21 GMTAI-designed SARS-CoV-2 variants escape prevalent antibodies - Phys.orgPhys.org · Tue, 28 Jul 2026 07:00:00 GMTBiointron Launches RushData to Accelerate AI-Driven Antibody Discovery with High-Throughput Experimental Validation - BioPharma APACBioPharma APAC · Tue, 28 Jul 2026 07:00:00 GMTAntibody Engineering: How Modern Antibody Technologies Are Transforming Healthcare - News-MedicalNews-Medical · Mon, 27 Jul 2026 07:00:00 GMT